Health Trials

Hypomethylating Agent

1

Review clinical trials related to Hypomethylating Agent. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Hypomethylating Agent and Venetoclax After Allo-HSCT in Patients With High-risk Myeloid Malignancies.

The main objective of the study is to evaluate the efficacy and safety of maintenance therapy with hypomethylating agent and Venetoclax to improve leukemia free survival for high-risk myeloid malignancies after allogeneic hematopoietic stem cell transplantation .

Participants needed: 78
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineUpdated: Aug 9, 2024Locations: 1
Eligibility criteria

Patients with AML or MDS and have received allogeneic hematopoietic cell transpl... [+5]

Concurrent use of targeted drugs ; [+9]

Read more